<DOC>
	<DOCNO>NCT00645372</DOCNO>
	<brief_summary>The purpose study compare efficacy safety ziprasidone risperidone treatment schizophrenia Chinese patient</brief_summary>
	<brief_title>A Study Compare Efficacy Safety Ziprasidone Risperidone Treatment Schizophrenia Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Hospitalized patient schizophrenia Miminum PANSS score 60 randomize Planned , regular use antipsyhotics within 1 week randomization Previous treatment risperidone result intolerance lack response risperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>